Market cap
$77.7B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-07
Alerts
8
Price$38.87 -7.78% 3M daily closessample
42.3337.10
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 22INS
- Oct 16INS
- Oct 07SEC
- Oct 02INS
- Sep 28INS
- Sep 21INS
- Sep 11INS
- Sep 08INS
Company facts
SEC EDGAR registration- Name
- Upstream Bio, Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- Smart-money score
- +54sample, -100 to +100
- Reporting currency
- USD
Who is positioning in UPB
sample- Insiders
- 15 insider transactions over 90 days, net selling, $804.2M
- Congress
- 1 members traded over 90 days
- Institutions · 13F
- 25 funds hold $540.3M
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$4.3B +15.9% y/y
Q4 2024Q3 2026
Inventory$2.4B +4.7% y/y
Q4 2024Q3 2026
Accounts receivable$1.9B +9.3% y/y
Q4 2024Q3 2026
Total debt$5.1B +17.4% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $72.3B +3.6% 3M
- Sample peer B
- $32.1B +16.3% 3M
- Sample peer C
- $52.4B +2.9% 3M
- Sample peer D
- $45.3B +12.6% 3M
- Sample peer E
- $53.1B +9.3% 3M